Cargando…
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
Aberrantly expressed onco-mucin 16 (MUC16) and its post-cleavage generated surface tethered carboxy-terminal (MUC16-Cter) domain are strongly associated with poor prognosis and lethality of pancreatic (PC) and non-small cell lung cancer (NSCLC). To date, most anti-MUC16 antibodies are directed towar...
Autores principales: | Shah, Ashu, Chaudhary, Sanjib, Lakshmanan, Imayavaramban, Aithal, Abhijit, Kisling, Sophia G., Sorrell, Claire, Marimuthu, Saravanakumar, Gautam, Shailendra K., Rauth, Sanchita, Kshirsagar, Prakash, Cox, Jesse L., Natarajan, Gopalakrishnan, Bhatia, Rakesh, Mallya, Kavita, Rachagani, Satyanarayana, Nasser, Mohd Wasim, Ganti, Apar Kishor, Salgia, Ravi, Kumar, Sushil, Jain, Maneesh, Ponnusamy, Moorthy P., Batra, Surinder K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421872/ https://www.ncbi.nlm.nih.gov/pubmed/37567918 http://dx.doi.org/10.1038/s41698-023-00423-7 |
Ejemplares similares
-
Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2014) -
ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2021) -
Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2015) -
RNA-based therapies: A cog in the wheel of lung cancer defense
por: Khan, Parvez, et al.
Publicado: (2021) -
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
por: Chaudhary, Sanjib, et al.
Publicado: (2023)